bf/NASDAQ:XERS_icon.jpeg

NASDAQ:XERS

Xeris Biopharma Holdings, Inc.

  • Stock

USD

Last Close

2.02

17/05 20:00

Market Cap

343.93M

Beta: -

Volume Today

1.24M

Avg: 1.25M

PE Ratio

−4.97

PFCF: −4.75

Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
asset turnover
0.03
-
0.03
7.86%
0.02
40.61%
0.02
21.61%
0.13
407.06%
0.16
28.66%
0.32
96.40%
0.48
50.30%
cash conversion cycle
-59.96K
-
-180.03K
200.24%
-7.10K
96.06%
-24.17
99.66%
329.39
1,462.61%
380.46
15.51%
426.67
12.15%
339.38
20.46%
cash per share
14.87
-
19.38
30.30%
9.35
51.75%
2.89
69.05%
3.14
8.43%
1.30
58.69%
0.90
30.62%
0.53
41.48%
company equity multiplier
-1.05
-
-0.78
25.90%
1.59
304.57%
7.55
374.30%
4.71
37.56%
3.20
32.20%
7.62
138.56%
-50.25
759.08%
days of inventory outstanding
495.47
-
326.85
34.03%
496.55
51.92%
398.88
19.67%
358.99
10.00%
days of payables outstanding
60.00K
-
180.31K
200.53%
7.53K
95.83%
1.28K
83.05%
121.97
90.44%
244.58
100.53%
74.28
69.63%
106.90
43.92%
days of sales outstanding
34.29
-
281.26
720.16%
424.82
51.04%
756.15
77.99%
124.50
83.53%
128.48
3.20%
102.07
20.56%
87.28
14.49%
dividend yield
0.33
-
0.46
38.28%
ebit per revenue
-12.31
-
-17.11
39.05%
-24.07
40.67%
-44.96
86.75%
-4.15
90.78%
-2.32
43.98%
-0.74
67.99%
-0.27
63.87%
ebt per ebit
1.00
-
1.00
0.12%
1.01
1.53%
1.03
1.73%
1.09
6.05%
1.07
2.42%
1.17
10.03%
1.44
23.05%
effective tax rate
0.00
-
-0.00
116.58%
-0.03
79,853.71%
0.00
112.07%
0.00
66.83%
0.01
-
0.02
32.71%
enterprise value multiple
-0.88
-
-0.07
92.17%
-3.31
4,675.02%
-1.86
43.65%
-3.22
72.59%
-2.20
31.55%
-3.61
63.84%
-15.73
336.05%
fixed asset turnover
3.45
-
1.97
42.69%
1.21
38.63%
0.35
71.40%
3.01
766.97%
7.48
149.01%
3.89
48.08%
5.62
44.60%
free cash flow per share
-7.43
-
-11.69
57.32%
-4.80
58.96%
-4.04
15.81%
-1.90
53.01%
-1.22
35.58%
-0.76
37.64%
-0.37
51.92%
gross profit margin
0.99
-
1.00
0.49%
0.98
1.45%
0.41
58.18%
0.54
30.67%
0.73
36.16%
0.79
8.65%
0.76
4.48%
interest coverage
-6.62K
-
-13.31K
101.26%
-23.32
99.82%
-17.09
26.73%
-7.84
54.13%
-16.04
104.64%
-5.35
66.66%
-1.65
69.07%
inventory turnover
0.74
-
1.12
51.59%
0.74
34.18%
0.92
24.49%
1.02
11.11%
long term debt to capitalization
0.30
-
0.80
169.68%
0.72
10.11%
0.48
33.31%
0.81
69.22%
1.04
27.53%
net income per ebt
1
-
1
0%
1
0%
1.00
0.36%
1.00
0.24%
1
0.12%
0.99
1.48%
0.98
0.49%
net profit margin
-12.29
-
-17.07
38.89%
-24.37
42.82%
-46.14
89.29%
-4.52
90.20%
-2.47
45.27%
-0.86
65.31%
-0.38
55.77%
operating cash flow per share
-7.41
-
-11.37
53.31%
-4.67
58.90%
-4.00
14.46%
-1.89
52.73%
-1.21
36.01%
-0.76
37.25%
-0.35
53.84%
operating cycle
34.29
-
281.26
720.16%
424.82
51.04%
1.25K
194.62%
451.35
63.94%
625.03
38.48%
500.95
19.85%
446.27
10.91%
operating profit margin
-12.31
-
-17.11
39.05%
-24.07
40.67%
-44.96
86.75%
-4.15
90.78%
-2.32
43.98%
-0.74
67.99%
-0.27
63.87%
payables turnover
0.01
-
0.00
66.73%
0.05
2,295.84%
0.29
489.90%
2.99
946.02%
1.49
50.13%
4.91
229.27%
3.41
30.52%
pretax profit margin
-12.29
-
-17.07
38.89%
-24.37
42.82%
-46.30
89.98%
-4.53
90.22%
-2.47
45.34%
-0.87
64.78%
-0.39
55.55%
price fair value
-1.37
-
-0.76
44.78%
2.72
458.00%
12.75
369.54%
6.21
51.26%
2.43
60.87%
3.99
64.18%
-47.71
1,295.02%
receivables turnover
10.64
-
1.30
87.81%
0.86
33.79%
0.48
43.82%
2.93
507.33%
2.84
3.10%
3.58
25.88%
4.18
16.94%
return on assets
-0.39
-
-0.59
49.81%
-0.50
15.18%
-1.15
130.20%
-0.57
50.30%
-0.40
29.59%
-0.27
31.86%
-0.18
33.51%
return on capital employed
-0.43
-
-0.66
55.47%
-0.54
18.58%
-1.50
177.46%
-0.64
57.43%
-0.51
19.90%
-0.30
40.82%
-0.18
40.76%
return on equity
0.41
-
0.46
11.01%
-0.80
273.52%
-8.70
991.82%
-2.70
68.97%
-1.29
52.26%
-2.09
62.55%
9.18
538.19%
total debt to capitalization
-0.03
-
-0.05
59.16%
0.35
850.50%
0.80
130.87%
0.72
10.11%
0.48
33.31%
0.81
69.47%
1.04
27.25%

All numbers in USD (except ratios and percentages)